Benzimidazole Building-Block Selection Guide: How Three “Knobs” (N Position / C2 Position / Benzene Ring) Drive Properties and Use Cases (Tables 1–4B)

1.The practical problem: why “a small heterocycle” can determine whether a molecule is truly usable

In drug discovery, agrochemical R&D, and functional materials development, you often face the same kind of choice:

a) You need a fragment that is small enough, yet can deliver predictable molecular interactions (hydrogen bonding / coordination / π interactions), while remaining usable in real environments with workable stability and tunability (acid–base state, solubility, morphology / processing window).

b) Many heterocyclic systems either lack “predictable interaction handles” (H-bond donors/acceptors or coordination sites are unclear, or hard to present reliably), or offer only a narrow window for tuning physicochemical properties (acid–base behavior, polarity, and solubility are difficult to balance; morphology tends to drift across conditions and batches). The common outcome is: activity/performance looks valid at first, but problems show up during formulation, film formation, or scale-up—for example, salt form/solubility cannot be stabilized, thin-film morphology is unstable, or batch-to-batch variability grows after process scaling.

Benzimidazole keeps reappearing because it compresses three key capabilities into a very small scaffold:

①. A two-nitrogen motif that, in the neutral state, often presents a “one donor + one acceptor” hydrogen-bonding template: one N more often acts as an acceptor, while the other provides an N–H donor. Tautomerism and protonation can switch “which N plays which role,” enabling interaction-mode switching when needed; it can also participate in metal coordination/complexation in some contexts.

②. Protonatability, enabling switching among “charge ↔ solubility ↔ interaction mode” across environments (the pKa of its conjugate acid is commonly around ~5.4–5.6, with shifts depending on substitution and medium).

③. A fused aromatic framework that provides structural stability and π-system rigidity, making it easier—both in drug-like systems and in materials—to maintain relatively predictable conformations and packing tendencies.

2.Definitions and core concepts

2.1 What is benzimidazole?

Benzimidazole is a fused aromatic heterocycle: it can be viewed as a bicyclic system formed by “a benzene ring fused to an imidazole ring.” The most common parent is 1H-benzimidazole, with molecular formula C₇H₆N₂.

 

 

2.2 What does “heterocyclic building block” mean?

In R&D and synthesis contexts, “heterocyclic building block” emphasizes its role:

1. As a reusable starting fragment (building block / fragment);

2. Extending outward from specific positions (commonly the N position or the 2-position) to attach “functional arms” (pharmacophores, coordination arms, conjugated segments, side chains, etc.);

3. Achieving clear control of properties and interactions with a small structural cost.

2.3 Tautomerism and protonation

The N–H position in benzimidazole can undergo prototropic tautomerism: within the same scaffold, the proton can redistribute between different nitrogens under different environments. In addition, it can be protonated to form a benzimidazolium species. These “state switches” directly change:

①. Which nitrogen behaves more like an H-bond acceptor, and whether N–H serves as a donor;

②. Solubility and the strength of ionic interactions;

③. How it binds to targets/acids/ions/polymer segments.

3.Structural features: three key modification sites determine how properties change

As a building block, benzimidazole is most useful when you treat three sites as adjustable “knobs”: the N position, the 2-position, and benzene-ring substitution. They map respectively to interaction mode, tunable charge, and expandable interfaces.

3.1 Three modification sites (“structural knobs”): what properties they change and what you can observe

Structural knob	Primary properties changed	Observable outcomes
N position (retain N–H vs N-substitution)	H-bond donor/acceptor pattern, tautomeric behavior; tendency toward protonation and salt formation	Binding mode changes; solubility/salt form becomes tunable; the system’s “state” becomes more single-defined or more switchable
2-position (most-used “interface position”)	Electronic effects and sterics; geometry at the linkage point; whether a stronger coordination/recognition “handle” is formed	Convenient for attaching pharmacophores/coordination arms/conjugated segments; more efficient SAR or property tuning in materials
Benzene-ring substitution (electron-donating/withdrawing + sterics)	pKa and polarity/hydrophobicity; π-stacking and morphology tendencies	Tunable activity/selectivity and ADMET; tunable film morphology and processing window (materials)

4.Classification: four types defined by the “structural knobs”

Category	Structural features	Advantages	Typical scenarios
A. N–H retained (tautomeric, salt-forming)	Retains ring N–H (proton can potentially migrate between the two nitrogens); readily protonated by acids to form salts	Switchable interaction modes; salt forms can tune solubility and binding mode	Salt-form tuning for solubility and SAR optimization in drug/agrochem scaffolds; binding designs requiring H-bond networks; also commonly used as a starting point for further N- or C2-modification
B. N-substituted neutral (no N–H; more stable/controllable)	Introduces alkyl/aryl at N; no N–H (so N–H tautomerism no longer occurs); reduced H-bond donor capability, often more hydrophobic	Fewer “state changes,” less uncertainty from strong H-bond donation, easier to stabilize properties	Prefer predominantly neutral behavior; reduce solubility/polymorph variability driven by strong H-bond donation; materials systems needing a more stable neutral fragment; or cases where overly strong interactions with metals/ions could cause side reactions (still system-dependent)
C. C2-functionalized linkage type (interface building block)	Adds substituents at the 2-position, treating it as a “connection port” to attach pharmacophores, coordination arms, conjugated segments, side chains, etc.	Turns benzimidazole from a “scaffold” into an “expandable interface”	Pharmacophore assembly and SAR expansion; building coordination/chelating fragments; extending conjugation and side-chain engineering in materials; construction where a clearly defined linkage site is needed
D. Ionic derivatives (a positively charged toolbox)	Achieves cationization via reversible protonation (salt formation) or further N-alkylation to form benzimidazolium salts (azolium; commonly N,N′-disubstituted) for more persistent cationic character; can serve as a starting point toward NHC precursors	Directly rewrites solubility, ionic interactions, and interfacial behavior through “charge state”	Systems needing ionic interactions or interfacial/phase-transfer capability; ionic liquids/electrolytes or ionic-polymer design; and N,N′-substituted benzimidazolium salts can be used as starting points to generate NHC (carbene ligands) for metal coordination/catalysis ligand construction

5.Quick overview of typical applications: three benzimidazole “application tracks” × common modification patterns (mapped to Section 4, A–D)

Application track	The “real-world problem” it addresses	Common modification approach (Section 4)	Key points
Medicinal chemistry: small scaffold for molecular recognition + property tuning	You need predictable binding features, while being able to tune solubility/charge state/polarity into a “usable window.”	Often start from A (N–H retained) and/or C (C2 interface); move to B (N-substituted) when a more stable neutral state is needed.	The literature often treats benzimidazole as a privileged scaffold: a small core that can simultaneously encode designable interactions (H-bonding, aromatic stacking, etc.) while enabling rapid SAR expansion.
Fungicides (agrochemicals): clear target → high efficacy, but also resistance pressure	Concentrated, target-specific action can be strong, but can be “bypassed” by target mutations.	Frequently benzimidazole derivatives with specific substitution patterns (can be understood as combined use of A/B/C, where substitution governs distribution/stability/affinity).	Representative benzimidazole fungicides (e.g., carbendazim, benomyl, thiabendazole) interact with β-tubulin and inhibit microtubule polymerization—an important mechanistic basis. Because this is site-specific action, practice typically emphasizes rotation or mixing with agents of different modes of action to reduce resistance risk.
Materials: PBI (polybenzimidazole) tackles harsh conditions with “high thermal stability + proton conduction”	You want membrane stability and sustained proton conduction under high temperature/low humidity conditions.	When benzimidazole is incorporated into the polymer backbone to form PBI, it essentially corresponds to “writing the protonatable capability of A/D into the materials system.”	The IUPAC Gold Book explicitly notes that polybenzimidazoles have high thermal stability and are proton-conducting polymers, suitable for fuel-cell membranes, etc. Engineering practice often uses acid doping (e.g., phosphoric acid) for high-temperature proton conduction, but this introduces trade-offs such as acid migration and mechanical balance—requiring co-optimization of structure and formulation.

6.Work backward from your goal: which benzimidazole type should you choose?

R&D need	Structural knob to prioritize	Typical starting type
Need a clear H-bond network / want salt formation to tune solubility	N position (N–H / protonation)	A. N–H retained type
Want a more single-defined state; reduce uncertainty from tautomerism and shifts in “donor/acceptor/coordination ability”	N position (N-substitution)	B. N-substituted neutral type
Want to use it as a “platform interface” to attach pharmacophores / coordination arms / conjugated segments	C2 position (interface site)	C. C2-functionalized linkage type
Need charge/ion pairing to drive solubility, interfacial behavior, or electrostatics; or want an NHC (carbene ligand) route	Charge state (azolium salt)	D. Benzimidazolium salts / ionic type

7.Benzimidazole-related chemicals: choose the right table quickly by research task (Tables 1–4B)

Research/experimental need	Which table to consult first	Selection logic	Representative products in the table
PPI (proton pump inhibitor) work: methods, impurity profiling, stability and process comparison, scaffold benchmarking	Table 1: Pharmaceutical APIs	PPIs are the most concentrated and mainstream benzimidazole drug line; Table 1 provides commonly used PPI APIs directly, making it a good starting point for analytical and reference standards.	Esomeprazole, omeprazole, lansoprazole, pantoprazole, rabeprazole
Benzimidazole anthelmintics: API reference, efficacy/analytical validation	Table 1: Pharmaceutical APIs	Anthelmintics are another classic “benzimidazole scaffold landing into medicines” use case; starting from API-grade samples makes it easier to build analytical and reference systems.	Albendazole
Benzimidazole fungicides/preservatives: agricultural activity screening, resistance/residue analysis references	Table 2: Agrochemicals / Preservatives	The core need is “active reference + analytical method/residue work”; Table 2 focuses on representative fungicides and commonly used standards, matching the experimental entry point.	Thiabendazole, carbendazim, (benomyl / related carbamate types)
Sunscreen / UV absorption & photostability: formulation screening, photoaging evaluation, UVB absorber benchmarking	Table 3: Personal care / Optical	UV work typically needs two material types: “chromophore scaffold” + “water solubility/formulation compatibility”; Table 3 provides benzimidazole UV scaffolds and sulfonated water-soluble UVB absorbers.	2-phenylbenzimidazole; 2-phenyl-5-benzimidazolesulfonic acid
Need a parent core / simple substitutions for structure controls: test how H-bonding/acid–base/hydrophobic tuning impacts properties	Table 4A: Building blocks (core / N-position / C2-alkyl & electronic tuning)	Table 4A is characterized by “minimal structures, most controllable variables,” ideal for initial structure–property/structure–activity comparisons (set direction first, then move to complex intermediates).	Benzimidazole (BZI), 1-methylbenzimidazole, 2-methyl/ethyl/propyl benzimidazole, 2-(trifluoromethyl)benzimidazole
Metal complexation / corrosion inhibition / metal capture, etc.: need stronger metal-binding ability (incl. sulfur coordination)	Table 4A: Building blocks	Sulfur-containing motifs (thiol/thio-) are among the most direct “coordination handles”; if the goal is metal interaction/corrosion inhibition/additive benchmarking, start from these building blocks first.	2-mercaptobenzimidazole
Ionic derivatives / NHC ligand precursors: build benzimidazolium salts; explore metal complexes/catalytic systems	Table 4A: Building blocks	Benzimidazolium salts = positively charged benzimidazole salts: commonly used in “ionic properties/ionic interactions” studies and often as starting points for preparing NHC ligands for metal complexes/catalysis; for such work, consult Table 4A first.	1,3-dimethyl-1H-benzimidazolium iodide
Rapid library expansion: C2 nucleophilic substitution/coupling/side-chain introduction (most common “handle position”)	Table 4B: C2 handles + benzene-ring functionalization	C2 is one of the most frequent derivatization entry points (alongside N-substitution and ring functionalization); Table 4B covers common C2 and ring “handles” (halides, chloromethyl, hydroxymethyl, aldehyde, carboxylic acid, 2-amino, etc.) for fast library build-out and positional controls.	2-chloro/2-bromobenzimidazole; 2-(chloromethyl)benzimidazole; 2-(hydroxymethyl)benzimidazole; benzimidazole-2-carbaldehyde; 1H-benzimidazole-2-carboxylic acid; 2-aminobenzimidazole
Ring-position coupling / positional controls: introduce substituents at 4/5/6/7 to tune electronics and sterics	Table 4B: benzene-ring functionalization	If the aim is “modify properties/activity/morphology via benzene-ring substitution,” ring halides and nitro/amino/carboxylic acid/aldehyde groups are the most common entry points; Table 4B concentrates these position-functionalized intermediates.	4-fluoro-1H-benzimidazole; 5-chloro/5-fluorobenzimidazole; 6-bromobenzimidazole; 7-bromo/7-chloro-1H-benzo[D/d]imidazole; 6-nitrobenzimidazole; 5-aminobenzimidazole; benzimidazole-5-carboxylic acid; 1H-benzimidazole-5-carbaldehyde
Route planning from building blocks to applied targets: choose scaffold first, then decide drug/agro/UV/material direction	Table 4A → Table 4B → Tables 1/2/3	A typical workflow is: use Table 4A to set scaffold & property direction, then use Table 4B to pick synthetic handles for expansion, and finally move to APIs/actives/UV components (Tables 1/2/3) for benchmarking and evaluation.	Start with BZI / 1-methyl / 2-alkyl / CF₃ controls → expand with 2-halides / 2-aldehyde / 2-carboxylic acid / ring halides → finally benchmark against PPIs / fungicides / UV absorbers

Table 1 | Pharmaceutical APIs | Benzimidazole Drugs (PPI Acid-Suppressants + Anthelmintics)

Category	CAS No.	Aladdin Cat. No.	Name	Spec / Purity	Key features & applications
Pharmaceutical API | PPI (benzimidazole-type acid suppressants)	119141-88-7	S586538	Esomeprazole	Moligand™, ≥99%	A representative proton pump inhibitor (PPI) API based on a benzimidazole scaffold; used in drug research for acid-related disorders, quality control, and method development/impurity profiling benchmarks. The benzimidazole motif provides a protonatable site and characteristic pharmacophore features.
Pharmaceutical API | PPI (benzimidazole-type acid suppressants)	103577-45-3	L129650	Lansoprazole	Moligand™, ≥98%	Representative PPI API; used for acid-suppressant R&D and analytical benchmarking. The benzimidazole scaffold is amenable to property tuning via substitution, including hydrophobicity and salt/polymorph-related behavior (system-dependent).
Pharmaceutical API | PPI (benzimidazole-type acid suppressants)	73590-58-6	O118724	Omeprazole	Moligand™, ≥98%	Classic PPI representative; used in acid-suppressant development and as a reference for stability and impurity analysis; often employed as a sample for structure/process studies of benzimidazole-based drug scaffolds.
Pharmaceutical API | PPI (benzimidazole-type acid suppressants)	102625-70-7	P302094	Pantoprazole	Moligand™, ≥97%	PPI API; used for pharmacology/formulation and analytical comparisons. The benzimidazole scaffold plus substituent set illustrates a typical drug-design workflow of “structural tuning → property window control.”
Pharmaceutical API | PPI (benzimidazole-type acid suppressants)	117976-89-3	H172338	Rabeprazole	Moligand™, ≥97%	PPI API; used for drug development and quality/method benchmarking. The benzimidazole core provides key interactions and protonatable character, making it a useful reference for structure–property comparisons.
Pharmaceutical API | Anthelmintic (benzimidazole class)	54965-21-8	A131023	Albendazole	≥98%	Benzimidazole-class anthelmintic API; used in parasitic infection research, drug analysis, and reference comparisons—representing a typical “landing point” of the benzimidazole scaffold in bioactive molecules.

Table 2 | Agrochemicals / Preservatives | Benzimidazole Fungicides (Representative Actives)

Category	CAS No.	Aladdin Cat. No.	Name	Spec / Purity	Key features & applications
Agro/animal health | Representative benzimidazole fungicide/anthelmintic	148-79-8	T276605	Thiabendazole	≥99%	Representative benzimidazole active: widely used for fungicidal/preservative applications and for studies on mechanism, resistance, and residue analysis; also commonly used as a benchmark sample for benzimidazole bioactive scaffolds.
Agrochemical | Fungicide (benzimidazole class)	10605-21-7	C140191	Carbendazim	≥97%	Representative benzimidazole fungicide; commonly used in agricultural disease-control research and residue-analysis benchmarking, and also in resistance and structure–activity relationship studies.
Agrochemical | Fungicide (benzimidazole class)	17804-35-2	B197283	Methyl 1-(butylcarbamoyl)-2-benzimidazolecarbamate	≥97%	Representative systemic benzimidazole fungicide (commonly used in agricultural disease-control research); used for benchmarking fungicidal activity, resistance, and residue analysis, illustrating a classic agrochemical application of the benzimidazole scaffold.

Table 3 | Personal Care / Optics | Sunscreen and UV-Absorbing Scaffolds (Benzimidazole Chromophores)

Category	CAS No.	Aladdin Cat. No.	Name	Spec / Purity	Key features & applications
Personal care / optics | UV absorber / chromophore scaffold	716-79-0	P101541	2-Phenylbenzimidazole	≥98%	A typical “benzimidazole + aryl” chromophore/UV-absorbing scaffold: often used as a structural benchmark in photostability/UV-absorption materials and formulation work, and also as a parent scaffold for further substitution optimization.
Personal care / sunscreen | Water-soluble UVB absorber	27503-81-7	P160598	2-Phenyl-5-benzimidazolesulfonic acid	≥95% (T)	A representative water-soluble UVB absorber scaffold (commonly used in sunscreen formulations); used in sunscreen formulation development, photostability/photoaging evaluation, and analytical benchmarking.

Table 4A | Heterocyclic Building Blocks | Parent Core / N-Position / C2-Alkyl & Electronic Tuning

Category	CAS No.	Aladdin Cat. No.	Name	Spec / Purity	Key features & applications
Basic building block | Parent core (unsubstituted)	51-17-2	B106095	Benzimidazole (BZI)	AR, ≥98% (HPLC)	Parent benzimidazole core building block: can be protonated to form salts; can participate in H-bonding/coordination. Commonly used as a starting point and reference sample for drug scaffolds, coordination/ligand fragments, and functional materials (e.g., polymers containing benzimidazole units).
Basic building block | N-substituted (lock N position / tune hydrophobicity)	1632-83-3	M110306	1-Methylbenzimidazole	≥99%	N-substituted benzimidazole: reduces N–H tautomerism/donor behavior and increases neutral/hydrophobic character; often used for drug/material structure controls, coordination chemistry, and salt-form comparison studies.
Basic building block | 5,6-dimethyl substitution on the benzene ring (bio-relevant fragment)	582-60-5	D109360	5,6-Dimethylbenzimidazole (5,6-DBI)	≥99%	Classic substituted benzimidazole (5,6-DBI): commonly used as a reference fragment in vitamin B12–related studies; also frequently used as a heterocyclic building block for structural controls and downstream derivatization.
Ionic salt / ligand precursor | Benzimidazolium salt (NHC-precursor context)	7181-87-5	D487249	1,3-Dimethyl-1H-benzimidazolium iodide	≥98%	Benzimidazolium salt: a positively charged benzimidazole salt. Commonly used to prepare NHC (N-heterocyclic carbene) ligands and further build metal complexes/catalytic systems; also used as a model organic salt for ionic-interaction studies (ion pairing, anion effects).
Functional building block | C2-mercapto / thio- (coordination/additive context)	583-39-1	M111104	2-Mercaptobenzimidazole	≥98%	Sulfur-containing benzimidazole building block: relevant to metal chelation/coordination and antioxidant contexts; commonly used in corrosion inhibition, metal capture/complexation, and as a materials additive reference (e.g., in rubber systems).
Basic building block | C2-alkyl substitution (tune hydrophobicity / SAR)	615-15-6	M110232	2-Methylbenzimidazole	≥98%	C2-methyl substituted basic building block: often used for quick steric/hydrophobic controls and structure–property validation; can serve as a starting scaffold for further functionalization.
Basic building block | C2-alkyl substitution (tune hydrophobicity / SAR)	1848-84-6	E191727	2-Ethylbenzimidazole	≥98%	Simple C2-alkyl substituted building block: used for SAR and hydrophobicity/solubility tuning benchmarks; also a starting scaffold for further functionalization.
Basic building block | C2-alkyl substitution (tune hydrophobicity / SAR)	5465-29-2	P303953	2-Propylbenzimidazole	≥97%	C2-propyl substituted building block: used for steric/hydrophobic tuning controls and SAR exploration; also a starting point for further functionalization.
Basic building block | Strong electron-withdrawing substitution (property tuning)	312-73-2	T588681	2-(Trifluoromethyl)benzimidazole	≥95%	CF₃-substituted building block: combines strong electron-withdrawing character with hydrophobic tuning; used to tune acidity/basicity, lipophilicity, and stability windows—commonly applied as a benchmark in medicinal chemistry and functional-molecule optimization.

Table 4B | Heterocyclic Building Blocks / Intermediates | C2 “Reactive Handles” + Benzene-Ring Functionalization (Entry Points for Coupling / Further Derivatization)

Category	CAS No.	Aladdin Cat. No.	Name	Spec / Purity	Key features & applications
Synthetic intermediate | C2 amino (amide/urea formation)	934-32-7	A104845	2-Aminobenzimidazole	≥97%	C2-amino building block: a high-frequency entry point for diverse derivatives (amides/ureas/sulfonamides, etc.); can also serve as a coordination site; widely used in scaffold assembly and functional-molecule design.
Synthetic intermediate | C2 halide (nucleophilic substitution / coupling entry)	4857-06-1	C137611	2-Chlorobenzimidazole	≥97%	High-reactivity C2-halide entry: convenient for nucleophilic substitution such as amination and thioether formation, and also usable for coupling-based expansion; enables rapid construction of multi-substituted benzimidazole libraries.
Synthetic intermediate | C2 halide (nucleophilic substitution / coupling entry)	54624-57-6	B136188	2-Bromo-1H-benzimidazole	≥97%	C2-bromo intermediate: used for coupling and nucleophilic substitution expansion; suitable for building substituted benzimidazole libraries and structure–property controls.
Synthetic intermediate | C2 chloromethyl (alkylation interface)	4857-04-9	C103613	2-(Chloromethyl)benzimidazole	≥96%	Chloromethyl “strong linkage interface”: used for N-alkylation/side-chain installation and for constructing quaternary/ionic derivatives; common in medicinal-chemistry side-chain assembly and functional-molecule construction.
Synthetic intermediate | C2 hydroxymethyl (linker / further conversion)	4856-97-7	B101392	2-(Hydroxymethyl)benzimidazole	≥97%	Hydroxymethyl linker: can be further oxidized/substituted or used to introduce side chains; commonly used to install “flexible linkage positions” in medicinal chemistry and materials molecules.
Synthetic intermediate | Aldehyde (condensation / reductive amination entry)	3314-30-5	H183754	Benzimidazole-2-carbaldehyde	≥95%	C2-aldehyde intermediate: used for condensation/reductive amination for side-chain installation; common in medicinal chemistry, coordination ligands, and functional-molecule construction, enabling rapid series generation.
Synthetic intermediate | Carboxylic acid (connection point / salt formation)	2849-93-6	H134909	1H-Benzimidazole-2-carboxylic acid	≥97%	C2-carboxylic acid building block: often used as a connection point to build “salt-forming/couplable” derivatives; also used in coordination chemistry (carboxylate + N-site cooperation) and functional-molecule design.
Synthetic intermediate | Benzene-ring amino (coupling / amide formation)	934-22-5	A151159	5-Aminobenzimidazole	≥98% (HPLC)	Amino-functionalized building block: enables rapid expansion via amidation/sulfonylation/urea formation to build substituted benzimidazole libraries; can also act as a coordination site for metal complexation and functional-molecule design.
Synthetic intermediate | Benzene-ring nitro (electronic tuning / reducible)	94-52-0	N105969	5-Nitrobenzimidazole	≥98%	Nitro-substituted intermediate: used for electronic-effect tuning and as a precursor to amino derivatives via reduction; commonly used to build multi-substituted libraries and for structure–property controls.
Synthetic intermediate | Carboxylic acid (connection point / salt formation)	15788-16-6	B107472	Benzimidazole-5-carboxylic acid	≥98%	Carboxylic-acid functionalized building block: convenient for amidation/salt formation and side-chain installation; commonly used in medicinal chemistry connection-point design, coordination chemistry, and functional assembly.
Synthetic intermediate | Aldehyde (condensation / reductive amination entry)	58442-17-4	H185372	1H-Benzimidazole-5-carbaldehyde	≥97%	Aldehyde intermediate: used for condensations (Schiff bases), reductive amination, and further functionalization; commonly used in ligand construction, side-chain installation on drug scaffolds, and library expansion.
Synthetic intermediate | Benzene-ring halide (coupling entry)	4887-82-5	C153428	5-Chlorobenzimidazole	≥98%	Benzene-ring halogenated benzimidazole: often used as a coupling/functionalization entry to build substituted libraries; supports rapid expansion toward drug scaffolds, coordination ligands, and materials monomers.
Synthetic intermediate | Benzene-ring halide (coupling entry)	1977-72-6	F191875	5-Fluorobenzimidazole	≥97%	Benzene-ring fluoro building block: used for fine-tuning electronic effects/hydrophobicity and for coupling-based expansion; commonly used in medicinal chemistry for property optimization and control studies.
Synthetic intermediate | Benzene-ring halide (coupling entry)	4887-88-1	B137245	6-Bromo-1H-benzimidazole	≥97%	Benzene-ring bromo building block: a typical coupling entry; enables rapid construction of multi-substituted libraries (drug/ligand/material monomer directions).
Synthetic intermediate | Benzene-ring halide (coupling entry)	5847-89-2	F697476	4-Fluoro-1H-benzimidazole	≥95%	Benzene-ring fluoro intermediate: used for subtle electronic tuning and coupling expansion; common in medicinal-scaffold optimization and positional controls.
Synthetic intermediate | Benzene-ring dihalide (coupling / electronic tuning)	6478-73-5	D185790	5,6-Dichlorobenzimidazole	≥95%	Dichloro-substituted building block: used to enhance electron-withdrawing effects and enable further coupling expansion; suitable for multi-substituted library building and structure–property relationship studies.
Synthetic intermediate | Benzene-ring halide (coupling entry)	16931-35-4	C191461	7-Chloro-1H-benzo[D]imidazole	≥95%	Benzene-ring chloro intermediate: used for coupling/functionalization expansion and positional controls; commonly used to build structural libraries for drugs, coordination ligands, and materials monomers.
Synthetic intermediate | Benzene-ring halide (coupling entry)	83741-35-9	B186835	7-Bromo-1H-benzo[d]imidazole	≥97%	Benzene-ring bromo building block: used for coupling/functionalization expansion; suitable for positional controls and substituted scaffold library building (especially for structure–property studies).

Note: The above items are representative Aladdin products. For additional specifications, please refer to the product list at the end of the document, or search the Aladdin website using “product name / CAS / catalog number.”

For more related articles, please see below:

Applications of imidazole and its derivatives

Homobenzotetramisole (HBTM): A General Organocatalyst for Asymmetric Acylations

MacMillan Imidazolidinone Organocatalysts

1,3-Dimethylimidazol-2-ylidene borane (diMe-Imd-BH3)